Glenmark Pharma Q2 Results : Co posts Rs 355 crore net profit on robust sales (...)
Glenmark Pharma reported Rs 340 crore net profit in Q2FY25 led by robust sales growth in India and Europe. The drugmaker reported a net loss of Rs 180 crore in the corresponding quarter of the previous year.
Site référencé: The Economic Times
The Economic Times
Gold bounces from lows after prices fall by Rs 1,500/10 grams this week. Can yellow metal rally further ?
13/08/2025
Apollo Hospitals Enterprise shares surge over 6% after Q1 net profit rises 42%
13/08/2025
Vikram Solar fixes Rs 315-332 price band for IPO. Check GMP, key dates, other details
13/08/2025
RVNL shares slip 4% as Q1 profit plunges nearly 40%
13/08/2025
Andrew Ferris warns S&P 500 rally is ‘superbly overvalued’
13/08/2025
Nykaa shares rally 5% as brokerages turn more bullish post Q1 results. Should you buy, sell or hold ?
13/08/2025
